|
1 |
Creative Commons |
Series 2 Episode 7 - Why research regulation falls short in genomic medicine |
As a society, we tend to focus a lot on risk and try to control it through regulation - but how well does that work for ensuring ethical practice in genomics? We talk to Dr Kate Lyle about her research on this topic. |
Rachel Horton, Gabrielle Samuel, Kate Lyle |
02 May 2023 |
|
2 |
|
Series 2 Episode 6 - Diversifying genomics |
What are the ethical challenges with diversifying genomic data? We talk to Faranak Hardcastle about her work exploring this. |
Rachel Horton, Gabrielle Samuel, Faranak Hardcastle |
07 Mar 2023 |
|
3 |
|
Series 2 Episode 5 - Who's 'the patient' in genomic medicine? |
We live our lives alongside others, and our decisions have consequences for those close to us - what does this mean for how we define 'the patient' in genomic medicine? Susie Weller talks to us about this issue. |
Rachel Horton, Gabrielle Samuel, Susie Weller |
25 Jan 2023 |
|
4 |
Creative Commons |
Series 2 Episode 2 - Why context matters in genetic testing |
How can the same genetic finding can mean different things in different people? What does this mean for 'personalising' genetic results? Anneke Lucassen talks to us about this issue. |
Rachel Horton, Gabrielle Samuel, Anneke Lucassen |
18 Jul 2022 |
|
5 |
|
Series 2 Episode 1 - The environmental cost of personalised medicine |
How does personalised medicine impact on the environment? What does this mean for how we should collect and store data? Gabrielle Samuel talks to us about these issues. |
Rachel Horton, Gabrielle Samuel, Susie Weller |
16 Jun 2022 |
|
6 |
|
Genomic Medicine - hype or hope? |
For the Inaugural Radcliffe Lecture 2014 Professor Hugh Watkins explores the success and limitations of genome sequencing in simple Mendelian diseases and in complex disorders, against the backdrop of his ground breaking research into heart disease. |
Hugh Watkins |
13 Apr 2015 |
